EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.481
https://www.valueinhealthjournal.com/article/S1098-3015(22)02685-7/fulltext
Title :
EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02685-7&doi=10.1016/j.jval.2022.09.481
First page :
Section Title :
Open access? :
No
Section Order :
12290